Hepatic R2* is more strongly associated with proton density fat fraction than histologic liver iron scores in patients with nonalcoholic fatty liver disease. Issue 5 (14th October 2018)
- Record Type:
- Journal Article
- Title:
- Hepatic R2* is more strongly associated with proton density fat fraction than histologic liver iron scores in patients with nonalcoholic fatty liver disease. Issue 5 (14th October 2018)
- Main Title:
- Hepatic R2* is more strongly associated with proton density fat fraction than histologic liver iron scores in patients with nonalcoholic fatty liver disease
- Authors:
- Bashir, Mustafa R.
Wolfson, Tanya
Gamst, Anthony C.
Fowler, Kathryn J.
Ohliger, Michael
Shah, Shetal N.
Alazraki, Adina
Trout, Andrew T.
Behling, Cynthia
Allende, Daniela S.
Loomba, Rohit
Sanyal, Arun
Schwimmer, Jeffrey
Lavine, Joel E.
Shen, Wei
Tonascia, James
Van Natta, Mark L.
Mamidipalli, Adrija
Hooker, Jonathan
Kowdley, Kris V.
Middleton, Michael S.
Sirlin, Claude B. - Abstract:
- Abstract : Background: The liver R2* value is widely used as a measure of liver iron but may be confounded by the presence of hepatic steatosis and other covariates. Purpose: To identify the most influential covariates for liver R2* values in patients with nonalcoholic fatty liver disease (NAFLD). Study Type: Retrospective analysis of prospectively acquired data. Population: Baseline data from 204 subjects enrolled in NAFLD/NASH (nonalcoholic steatohepatitis) treatment trials. Field Strength: 1.5T and 3T; chemical‐shift encoded multiecho gradient echo. Assessment: Correlation between liver proton density fat fraction and R2*; assessment for demographic, metabolic, laboratory, MRI‐derived, and histological covariates of liver R2*. Statistical Tests: Pearson's and Spearman's correlations; univariate analysis; gradient boosting machines (GBM) multivariable machine‐learning method. Results: Hepatic proton density fat fraction (PDFF) was the most strongly correlated covariate for R2* at both 1.5T ( r = 0.652, P < 0.0001) and at 3T ( r = 0.586, P < 0.0001). In the GBM analysis, hepatic PDFF was the most influential covariate for hepatic R2*, with relative influences (RIs) of 61.3% at 1.5T and 47.5% at 3T; less influential covariates had RIs of up to 11.5% at 1.5T and 16.7% at 3T. Nonhepatocellular iron was weakly associated with R2* at 3T only (RI 6.7%), and hepatocellular iron was not associated with R2* at either field strength. Data Conclusion: Hepatic PDFF is the mostAbstract : Background: The liver R2* value is widely used as a measure of liver iron but may be confounded by the presence of hepatic steatosis and other covariates. Purpose: To identify the most influential covariates for liver R2* values in patients with nonalcoholic fatty liver disease (NAFLD). Study Type: Retrospective analysis of prospectively acquired data. Population: Baseline data from 204 subjects enrolled in NAFLD/NASH (nonalcoholic steatohepatitis) treatment trials. Field Strength: 1.5T and 3T; chemical‐shift encoded multiecho gradient echo. Assessment: Correlation between liver proton density fat fraction and R2*; assessment for demographic, metabolic, laboratory, MRI‐derived, and histological covariates of liver R2*. Statistical Tests: Pearson's and Spearman's correlations; univariate analysis; gradient boosting machines (GBM) multivariable machine‐learning method. Results: Hepatic proton density fat fraction (PDFF) was the most strongly correlated covariate for R2* at both 1.5T ( r = 0.652, P < 0.0001) and at 3T ( r = 0.586, P < 0.0001). In the GBM analysis, hepatic PDFF was the most influential covariate for hepatic R2*, with relative influences (RIs) of 61.3% at 1.5T and 47.5% at 3T; less influential covariates had RIs of up to 11.5% at 1.5T and 16.7% at 3T. Nonhepatocellular iron was weakly associated with R2* at 3T only (RI 6.7%), and hepatocellular iron was not associated with R2* at either field strength. Data Conclusion: Hepatic PDFF is the most influential covariate for R2* at both 1.5T and 3T; nonhepatocellular iron deposition is weakly associated with liver R2* at 3T only. Level of Evidence: 4 Technical Efficacy: Stage 2 J. Magn. Reson. Imaging 2019;49:1456–1466. … (more)
- Is Part Of:
- Journal of magnetic resonance imaging. Volume 49:Issue 5(2019)
- Journal:
- Journal of magnetic resonance imaging
- Issue:
- Volume 49:Issue 5(2019)
- Issue Display:
- Volume 49, Issue 5 (2019)
- Year:
- 2019
- Volume:
- 49
- Issue:
- 5
- Issue Sort Value:
- 2019-0049-0005-0000
- Page Start:
- 1456
- Page End:
- 1466
- Publication Date:
- 2018-10-14
- Subjects:
- nonalcoholic steatohepatitis -- NASH -- nonalcoholic fatty liver disease -- NAFLD -- proton density fat fraction -- PDFF -- R2* -- hepatic steatosis
Magnetic resonance imaging -- Periodicals
616 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1522-2586 ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1002/jmri.26312 ↗
- Languages:
- English
- ISSNs:
- 1053-1807
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 5010.791000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 9745.xml